Silverback Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Silverback Therapeutics, Inc.
CIK #0001671858
EDGAR Form CIK 2011 - 2025
10-K [0001671858]
10-Q [0001671858]
3 [0001671858]
4 [0001671858]
8-K [0001671858]
D [0001671858]
SC 13D [0001671858]
SC 13G [0001671858]
Form 13D/13G Filer Form 13D/13G Subject Filed
RA Capital Management LP ARS Pharmaceuticals Inc [2023-08-31]
Bell Robert G ARS Pharmaceuticals Inc [2022-11-21]
Tanimoto Sarina ARS Pharmaceuticals Inc [2022-11-18]
Lowenthal Richard E ARS Pharmaceuticals Inc [2022-11-18]
Pratik Shah Living Trust Dated June 15 2011 ARS Pharmaceuticals Inc [2022-11-18]
Flynn James E ARS Pharmaceuticals Inc [2022-11-18]
K2 Principal Fund LP Silverback Therapeutics Inc [2022-07-18]
Wasatch Advisors Inc Silverback Therapeutics Inc [2022-02-11]
US Venture Partners XII LP Silverback Therapeutics Inc [2022-01-27]
Nextech VI Oncology SCSP Silverback Therapeutics Inc [2021-02-16]
View All
Form 3/4/5 Subject 2011 - 2025
ARS Pharmaceuticals, Inc.
Karas Eric
Flynn James E
Deerfield Private Design Fund IV, L.P.
Deerfield Mgmt III, L.P.
Deerfield Management Company LP
Deerfield Mgmt IV, L.P.
Deerfield Private Design Fund III, L.P.
Schneider Phillip M
Dadoo Rajeev
View All
Terms | Privacy | Guide
tony@aum13f.com